title: Long-term prognosis of patients with acute coronary syndrome and moderate coronary artery stenosis.
abstract: We evaluated the clinical outcome and the prognostic factors at 6-year follow-up of patients with acute coronary syndrome without critical coronary arterial narrowing. The mean follow-up was 73 +/- 19 months. Mortality rate was 13%, and 20 patients (12%) had major cardiac event, 8 patients (5%) had stroke and 10 patients (6%) underwent revascularization. Multivariate analysis matched for age and ejection factor showed that moderate disease (stenosis 40-59%) (OR = 2.713, p < 0.024) was an independent predictive factor of major cardiac event.
authors.affiliation: Cardiology Department, Centre Hospitalier Universitaire, Dijon, France.
authors.forename: Thierry
authors.initials: T
authors.lastname: Maurin
authors.forename: Marianne
authors.initials: M
authors.lastname: Zeller
authors.forename: Yves
authors.initials: Y
authors.lastname: Cottin
authors.forename: Claude
authors.initials: C
authors.lastname: Touzery
authors.forename: Jean Claude
authors.initials: JC
authors.lastname: Beer
authors.forename: Isabelle
authors.initials: I
authors.lastname: L'Huillier
authors.forename: Michel
authors.initials: M
authors.lastname: Fraison
authors.forename: Philippe
authors.initials: P
authors.lastname: Buffet
authors.forename: Pierre
authors.initials: P
authors.lastname: Louis
authors.forename: Jean Eric
authors.initials: JE
authors.lastname: Wolf
mesh_terms: D000208:Acute Disease; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000368:Aged; D000789:Angina, Unstable / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology; D001241:Aspirin / Q000627:therapeutic use; D017023:Coronary Angiography; D003327:Coronary Disease / Q000175:diagnosis* / Q000188:drug therapy / Q000453:epidemiology; D023921:Coronary Stenosis / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology; D023381:Endpoint Determination; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D005500:Follow-Up Studies; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D011237:Predictive Value of Tests; D011379:Prognosis; D012189:Retrospective Studies; D012307:Risk Factors; D012720:Severity of Illness Index; D013318:Stroke Volume / Q000502:physiology; D016019:Survival Analysis; D013577:Syndrome; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D000319:Adrenergic beta-Antagonists; D005343:Fibrinolytic Agents; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D001241:Aspirin